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The  parasitic  protozoan Leishmania  enriettii contains 
a family  of  tandemly  repeated  genes,  designated  Pro-1, 
that  encode  proteins  with  significant  sequence  similar- 
ity  to  mammalian  facilitative  glucose  transporters. 
Pro-1 mRNAs are  expressed  almost  exclusively in the 
promastigote  or  insect  stage of the  parasite  life  cycle. 
The  Pro-1  tandem  repeat  encodes  two  isoforms  of  the 
putative  transporter,  iso-1  and  iso-2,  which  have  identi- 
cal  predicted  amino  acid  sequences  except  for  their NH,- 
terminal  hydrophilic  domains. We have  now  expressed 
both  iso-1  and  iso-2 by microinjecting  their RNAs into 
Xenopus oocytes  and  assaying  these  oocytes  for  trans- 
port  of  various  radiolabeled  ligands.  Both  iso-1  and  iso-2 
transport [3H]2-deoxy-~-glucose, confirming that each 
protein is a bona  fide  glucose  transporter.  Each  isoform 
also  transports  fructose  and,  to  a  much  lesser  degree, 
mannose. Compounds which inhibit 2-deoxy-D-gkcose 
transport in L.  enriettii promastigotes also inhibit  trans- 
port in the  microinjected  oocytes  expressing  each  iso- 
form, indicating that the substrate specificities and 
pharmacological  properties of each  isoform  are  similar 
to  those  measured  for  2-deoxy-D-glucose  transport  in  in- 
tact  parasites. The K,,, for  transport  of  2-deoxyglucose  in 
oocytes expressing iso-1 is similar to that for oocytes 
expressing  iso-2.  These  results  reveal  that  both  trans- 
porter  isoforms  have  closely  related  functional  proper- 
ties and  that  the  difference  in  their  structures  may  serve 
some other purpose such as differential subcellular 
localization. 
Leishmania are  parasitic protozoa of the  order Kinetoplas- 
tida  that  have two major developmental stages in their life 
cycle t 1). Promastigotes  are flagellated extracellular  organisms 
which live in  the  midgut of the sandfly vector, and  amastigotes 
are non-flagellated organisms that are adapted for survival 
within  the phagolysosomes of the  vertebrate host  macrophages. 
Glucose is a major  source of metabolic  energy in  the promas- 
tigotes (21, and  this  sugar is also metabolized, albeit at a lower 
level, in the amastigotes (3-5). The kinetic and biochemical 
properties of glucose transport by promastigotes of Leishmania 
donouani has been investigated previously (6). Transport of 
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2-deoxy-~-glucose (2-DOG)’ occurs by a carrier-mediated sys- 
tem  with high  affinity for the  substrate.  Other hexoses such  as 
fructose, mannose, glucosamine, ~-acetylglucosamine,  and ga- 
lactose can  inhibit  transport of 2-DOG with various a ~ n i t i e s  
(7), and some or  all of these compounds may  also be substrates 
for promastigote glucose transporters. A body  of experimental 
evidence suggests  that promastigotes  may  accumulate glucose 
via an active proton symporter  that utilizes an electrochemical 
gradient to  concentrate the  sugar  within  the  parasite (8). How- 
ever, this conclusion has recently been challenged on the  basis 
of different experiments involving growth of promastigotes at  
defined glucose concentrations within a chemostat (9, 10). The 
latter  authors  have contended that glucose transport probably 
occurs via a  facilitated transport mechanism. 
In a previous report (11) we have cloned a gene from Leish- 
mania enriettii which is related  in sequence and  putative sec- 
ondary  structure  to  mammalian glucose transporters.  This gene 
is expressed  almost exclusively in  the promastigote stage of the 
parasite life cycle and  has been designated  the Pro-1 gene. The 
Pro-1 sequences are  arranged as a family of -7-8 tandemly 
repeating  units  within  the  parasite genome (12). Sequencing of 
the  initial  unit  and of an  internal  unit of this  repeat revealed 
that  the  first copy in  the  repeat encodes a unique isoform (13) 
of the  Pro-1 protein (iso-1). This unique isoform contains  a dis- 
tinct NH,-terminal  domain compared to the  other members of 
the  repeat (iso-2). Hence, iso-1 and iso-2 form modular struc- 
tures containing unrelated  amino-terminal sequences attached 
to  the  remainder of the protein which is  apparently  identical in 
sequence. Furthermore,  these  distinct NH,-terminal segments 
appear to constitute  separate  structural domains, correspond- 
ing exactly to  the  hydrop~lic  tail  that  is located on the cyto- 
plasmic  surface of the  plasma  membrane  in  mammalian facili- 
tated glucose transporters (14,  15) (Fig. 1). 
A question of great  importance  regarding  the  Pro-l  proteins 
concerns their biochemical function. Although these  proteins 
are  related  in sequence to  other known transporters,  they  have 
not previously been  functionally  expressed to demonstrate con- 
clusively that they are transporters nor has their substrate 
specificity been determined. Since various  members of the glu- 
cose transporter superfamily (16) transport different  sub- 
strates, membership in  this family based upon sequence ho- 
mology alone cannot predict the  substrate(s) recognized by the 
protein. We have now expressed the  genes encoding both iso-1 
and iso-2 of Pro-1 in Xenopus oocytes and  demonstrated  that 
they  are  genuine glucose transporters. Functional character- 
ization of their  transport activities indicates  that  their bio- 
chemical and  kinetic properties are very similar  to each other 
and  that  any distinctions in  their biological roles are unlikely to 
be  related  to specific transport  characteristics. 
The  abbreviations  used are: 2-DOG, 2-deoxy-~-glucose; DCCD, 
N’,N’-dicyclohexylcarbodiimide, FCCP,  carbonyl  cyanide  p-trifluorome- 
thoxyphenylhydrazone. 
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EXPERIMENTAL PROCEDURES 
Materials-Cytochalasin B, N'JV"dicyclohexy1carbodiimide (DCCD), 
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), phlore- 
tin, phloridzin, and all sugars used as substrates or inhibitors were 
from Sigma. Radiolabeled sugars were purchased from  DuPont-NEN. 
DNA polymerase from Thermus aquaticus (Taq polymerase) was ob- 
tained from  Promega. 
Parasite Culture and Dunsport Assays-Promastigotes of L. enriettii 
were cultured at  27 "C in Dulbecco's  modified Eagle's-L  medium (17) 
containing 10% bovine  embryonic  fluid (Sigma). For transport assays, 
parasites were pelleted, washed  twice in phosphate-buffered saline, pH 
5 x 10' cells ml-'. Cells (100 pl) were then layered over 100 pl of 96% 
7.4, and resuspended in phosphate-buffered saline at a concentration of 
silicone  oil,  4% paraffin oil (Sigma) in  a microcentrifuge tube. Transport 
assays were initiated by adding to the  parasites radiolabeled substrate 
(usually [3H]2-deoxy-~-glucose at 3 x lo4 pCi  mmol") a t  the appropriate 
concentration. The suspension was then incubated for  60 s at ambient 
temperature,  and  the cells  were pelleted by centrifugation at 16,000 x 
g for  30 s. The aqueous phase was aspirated, the interface was washed 
twice with 500 pl of water, the oil  was aspirated,  and  the cell pellet was 
resuspended in 100 pl of 0.1%  Triton  X-100. Each sample was mixed 
with 2 ml of Bio-Safe I1 fluor (Research Products Int.) and counted on a 
liquid scintillation counter. 
Expression of iso-1 and iso-2 in Xenopus  Oocytes-For expression in 
Xenopus oocytes, the protein coding regions of iso-1 and iso-2 were 
subcloned into the EcoRI site of the oocyte expression vector pL2-5 (la), 
which contains Xenopus P-globin 5'- and 3"untranslated regions to  
optimize expression levels in oocytes. Synthetic RNAwas transcribed in 
vitro in  a 50-pl reaction containing 40 mM Tris, pH  7.5,  10 mM NaCl, 6 
m~ MgCl,, 2 mM spermidine, 500 1.1~ rNTPs, 2.5 mM cap analogue 
m7G(5')ppp(5')G (Pharmacia Biotech Inc.), 40 units of placental ribo- 
nuclease inhibitor (Promega), 1 m~ dithiothreitol, 1 pg of linear plasmid 
template DNA, and 50 units of T7 RNA polymerase (Promega). The 
reaction was incubated at 37  "C  for 45 min, a fresh aliquot of rNTPs and 
RNA polymerase were added, and the incubation was continued for 
another 45  min. The reaction was then incubated with 2  units of RQ1 
RNase-free DNase (Promega) for 15 min at 37 "C and then extracted 
with phenol and chloroform and precipitated with ethanol. Approxi- 
mately 50 ng of  RNA was injected into defolliculated stage V-VI Xenopus 
oocytes (19). The injected oocytes  were incubated for 4 days at 12 "C in 
ND-96 buffer containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl,, 1 m~ 
MgCl,, and 5 mM HEPES, pH 7.5. For transport assays, oocytes  were 
incubated in ND-96 with the appropriate radiolabeled ligand (e.g. c3H12- 
DOG a t   0 .84  x lo4 pCi mmol") for 1 h at ambient temperature, re- 
moved  from the ligand and rapidly rinsed three times in fresh ND-96, 
dissolved in 1 ml of 1% Triton  X-100,  mixed with 10  ml of Bio-Safe I1 
fluor, and counted on a liquid scintillation counter. 
Estimation of K,,, Values  from Substrate  Saturation Curves-K,,, val- 
ues were determined by fitting substrate saturation data by least 
squares to  the Michaelis-Menten equation (V = V,,S/[K,,, + SI) using 
the Kaleidagraph program (Synergy Software) employing the Leven- 
berg-Marquardt algorithm. In addition, double reciprocal plots were 
constructed and fitted by least squares linear regression using the 
Cricket Graph I11 program (Computer Associates). 
RESULTS 
Cloning of Entire  Protein Coding Region of iso-1-In a pre- 
vious report (13) we identified  iso-1 as a gene that is distinct 
from iso-2 by subcloning and sequencing a portion of iso-1 
which encodes amino  acids 1 through 437. To confirm that the 
only differences  between  iso-1 and iso-2 are  in  the  amino-ter- 
minal hydrophilic  domain and  to  obtain  functional expression 
of iso-1, it  was  first  necessary to  clone and sequence the com- 
plete  651-amino  acid coding region of this isoform. To obtain 
such a clone we designed one oligonucleotide primer which 
contained  sequence surrounding  the  amino  terminus of iso-1 
and a second primer which contained sequence immediately 
downstream from the carboxyl terminus of iso-2 (and  presum- 
ably  iso-1 as well) and  used  these  primers in the polymerase 
chain reaction (20) to amplify a 2-kilobase pair segment of 
genomic DNA from L. enriettii.  This polymerase chain  reaction 
amplified segment was subcloned and sequenced. The pre- 
dicted amino acid  sequence of this subclone (data  not  shown) 
revealed that iso-1 is indeed  identical  to iso-2 over the  entire 
iso-I 
Membrane 
Plasma 
FIG. 1. Schematic representation of iso-1 indicating the unique 
rows marked N l  ) which differs from iso-2. Black  circles designate 
NH2-terminal  domain (amino acids 1-132, delineated by the ar- 
amino  acids that are identical between  iso-1 and iso-2, whereas open 
circles are amino acids which are unique to iso-1. Putative transmem- 
brane domains (inside open rectangles) have been  predicted using the 
Eisenberg algorithm (35), plus signs are lysine or arginine residues, 
minus signs are aspartate or glutamate residues, and diamonds are 
charged residues within transmembrane domains. This figure has been 
modified  from a previous  depiction of iso-2 in Fig. 4 of Ref.  36. 
region beginning at amino acid 133 of iso-1 and continuing 
through carboxyl-terminal amino acid number 651. Hence the 
iso-1 and iso-2 proteins contain completely different amino- 
terminal  domains  (amino  acids 1-132  of iso-1 and  1-48 of iso- 
2), but  they  are  identical  in sequence beginning with the  first 
putative  transmembrane  segment  and  continuing  to  the  end of 
the  protein coding region  (Fig. 1). 
Functional Expression of iso-1 and iso-2 in Xenopus 
Oocytes-In order to express  each  Pro-1 isoform to  determine 
its function and  substrate specificity, the  protein coding regions 
of iso-1 and iso-2 were subcloned into  the Xenopus oocyte ex- 
pression  vector L2-5 (18). RNA was  prepared from each clone 
by transcription  with T7 RNA polymerase and microinjected 
intoxenopus oocytes. Four  days  after injection these oocytes, as 
well as controls microinjected with water, were assayed for 
transport of the glucose analogue [3H]2-deoxy-~-glucose 
(2-DOG). This  analogue has been utilized routinely  in  studies 
of glucose transport  in  Leishmania because it can be phospho- 
rylated by hexokinase  but  cannot be further metabolized by the 
parasites (6). Fig. 2 (A and B )  shows that oocytes expressing 
each isoform transported  this  ligand  at a linear  rate for at  least 
3 h and  accumulated  the  substrate  to a 50-fold higher level 
than  the control oocytes at the  3-h  time point. Furthermore, 
this  transport activity could be completely abrogated by  com- 
petition with unlabeled D-glucose but not L-glucose (Fig. 3). 
These  results prove conclusively that both  the iso-1 and iso-2 
forms of the  Pro-1  protein  are bona  fide glucose transporters. 
Previous studies on glucose transport by L. donouani (7)  have 
revealed that  transport of this  sugar  can be strongly  inhibited 
by other hexoses such  as  fructose  and  mannose  and  suggest 
that these  sugars  are  also likely to be substrates for the  para- 
site glucose transporter. The ability to functionally express 
cloned Leishmania glucose transporters now allows US to di- 
rectly test this hypothesis and to eliminate the alternative 
interpretation  that  these  inhibitors  might bind to  the active 
site of the  transporter  but fail t o  be transported.  In competition 
experiments (Fig. 3) we have confirmed that fructose and  man- 
nose can completely inhibit  transport of  [3H12-DOG in promas- 
tigotes of L. enriettii,  whereas  other  sugars  such as L-glucose or 
D-ribose have  little or no effect on transport of this ligand  even 
when included a t  a 200-fold higher  concentration  than  the  ra- 
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oocytes injected with iso-1 (A and C )  or iso-2 ( B  and D )  RNA. 
FIG. 2 .  Time courses for transport of radiolabeled sugars in 
Injected oocytes were incubated with 50 PM L3H12-DOG (O), 50 VM 
['4Clfructose (x), or 50 VM L3H1mannose (HI. For  each  time  point,  uptake 
into  three oocytes was measured and averaged; error burs represent 
standard  deviations of these  three  values. Open circles (0) represent 
control oocytes injected with water instead of RNA. The uninjected 
controls  in  parts C and D were measured in the presence of 50 PM 
P4Clfructose. 
Inhibitor 
None 
D-glucose (10 mM) 
L-glucose (10  mM) 
D-ribose (10  mM) 
D-galactose (10 mM) 
D-mannose (10 mM) 
D-fructose  (10 mM) 
D-fructose (250 mM) 
Cytochalasin B (500pM) 
Phloretin (300pM) 
Phloridzin (5mM) 
Forskolin (100pM) 
Ouabain  (1mM) 
DCCD  (100pM) 
FCCP (10pM) 
0 50 100 150 
% of control 
FIG. 3. Inhibition of rSH12-DOG transport  by  various reagents 
in promastigotes of L. enriettii  (solid  bars), and in oocytes in- 
jected with iso-1 (cross-hatched  bars) or iso-2 (dotted  bars) RNA. 
For each  measurement,  the  concentration of 2-DOG was 50 PM and  the 
concentration of inhibitor  was  as  indicated  in  the  figure.  Assays  in L. 
enriettii  were  performed for 1 min,  and  those  in oocytes for 1 h.  Each  bur 
represents the average of three independent measurements; values 
were  averaged,  and  error  bars  indicate  standard  deviations. 
diolabeled ligand. Fig. 2 (C and D )  demonstrates  that oocytes 
injected with iso-1 or iso-2 RNA are able to  transport 
~-['~Clfructose  and  ~-[~H]mannose  and accumulate these sug- 
ars to significantly higher levels than control oocytes. However, 
transport of mannose is relatively  weak compared to  2-DOG or 
fructose,  suggesting that mannose is a very poor substrate for 
both transporters. These results confirm that  these Leishma- 
nia glucose transporters have a relatively broad substrate 
specificity and  are able to recognize ligands that  are not sub- 
strates for mammalian glucose transporters such as GLUT1. 
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FIG. 4. Substrate saturation curves for r3H12-DOG measured in 
promastigotes of L. enriettii (A), in oocytes injected with iso-1 
RNA ( B ) ,  and in oocytes injected with iso-2 RNA ( C ) .  For each 
substrate  concentration, at  least  three  independent  samples  were  meas- 
ured  and  the  calculated velocities were  averaged;  error  bars  represent 
standard  deviations o f  these  values. Velocity values inA  are  per 5 x lo7  
parasites and in B and C are per oocyte. The insets display double 
reciprocal plots o f  the  data  in  the  saturation curves.  The  duration of 
transport  assays  was 1 min  in  promastigotes  and 1 h in oocytes. 
Estimation of Apparent K,,, Values for iso-1 and is0-2- 
Functional differences between glucose transporter isoforms 
can be reflected in distinct  kinetic parameters.  Thus isoforms of 
the  human facilitated glucose transporters often have signifi- 
cantly different K, values for glucose, correlated with their 
particular physiological roles and  with  the  range of substrate 
concentration over which they  must function optimally (21). 
Hence, it  is  important to  determine  whether  the  half-saturat- 
ing  substrate levels for iso-1 and iso-2 are different and might 
reflect distinct  functional roles for each isoform. 
Fig. 4 shows representative  substrate  saturation curves and 
double reciprocal plots (insets) for L3H12-DOG measured  in pro- 
mastigotes of L. enriettii (Fig. 4A) and  in oocytes expressing 
either iso-1 (Fig. 4B) or iso-2 (Fig. 4C). To estimate K, values 
for each system, at  least  three  independent  substrate  satura- 
tion curves were measured, and these data were fit t o  the 
Michaelis-Menten equation as described under "Experimental 
Procedures." Promastigotes of L. enriettii show reproducible K, 
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values of 53 f 0.6 p (n  = 3), in  reasonable  agreement  with  the 
K,  of 24.4 p measured previously in promastigotes of L. do- 
novani using similar methods (6). The kinetic values deter- 
mined  from saturation  curves  in injected oocytes are  less re- 
producible but  indicate a K,,, for iso-1 of 647 f 257 p~ (n  = 3)  and 
a K,  for iso-2 of 285 55 PM (n  = 4). Hence, the K, for iso-1 
appears to be slightly higher than that for iso-2 but is not 
dramatically different given the  scatter  inherent  in  these  meas- 
urements. However, the K,  values measured in oocytes are 
significantly higher  than  those  determined  in  the  parasites. To 
determine whether oligomerization of iso-1 and iso-2 could 
produce a transporter with higher substrate affinity, we co- 
expressed  both proteins  within single oocytes. The K, values 
obtained  in  these co-expression experiments (456 2 222 VM for 
n = 2) were  not significantly  different from those  measured  in 
oocytes expressing each isoform alone. 
Inhibition of 8-Deoxy-D-ghcose Bansport by Other Sub- 
strates  and  Inhibitors-In previous experiments  (7)  the  sensi- 
tivity of glucose transport  in whole promastigotes of L. dono- 
vani to inhibition by various  sugars  and organic reagents has 
been studied. In particular, D-glucose, D-fructose, D-mannose, 
N-acetyl-D-glucosamine, D-glucosamine, and o-galactose inhib- 
ited  transport of 2-DOG with  decreasing  order of affinity, sug- 
gesting that some or all of these sugars are substrates for 
promastigote glucose transporters. Cytochalasin B, which is a 
potent  inhibitor of mammalian  facilitated glucose transporters 
(221, inhibits glucose transport in promastigotes but does so 
with an IC,, of 55 PM (231, about 100-fold higher  than  that 
observed using mammalian systems. DCCD, an inhibitor of 
proton  ATPases, and FCCP, an ionophore that uncouples  proton 
gradients (23),  significantly inhibit glucose transport  in L. do- 
nouani promastigotes (81, consistent with a possible role for 
proton gradients in energizing glucose transport  in Leishmania 
species. 
We have  tested  the ability of these  reagents  to  inhibit  trans- 
port of 2-DOG in  promastigotes of L. enriettii and  in oocytes 
microinjected with iso-1 or iso-2 RNA. Fig. 3 shows that D- 
glucose, D-fructose, and D-mannose inhibit  transport of 2-DOG 
in  parasites  and  in oocytes injected with RNA for each isoform, 
whereas L-glucose,  D-ribose, and D-galactose do not  significantly 
inhibit  such  transport at  these concentrations.  Hence, in gen- 
eral  the  inhibition  patterns of iso-1 and iso-2 are very similar  to 
each other  and  to  that of glucose transport  in promastigotes of 
L. enriettii. One exception occurs in  relation  to fructose inhibi- 
tion of 2-DOG transport:  10 mM fructose will strongly  inhibit 
transport of 50 p 2-DOG in promastigotes but only inhibits 
such  transport by about 50% in oocytes injected with  either 
iso-1  or iso-2. However, 250 mM fructose will strongly  inhibit 
2-DOG transport  in microinjected oocytes. One possible expla- 
nation for this discrepancy is  that  the K, for fructose is higher 
in oocytes than it is in  the  parasites,  thus  requiring a higher 
concentration of fructose to  inhibit  transport of 2-DOG. 
Fig. 3 also shows inhibition by various organic reagents of 
2-DOG transport  in L. enriettii promastigotes and  in oocytes 
injected with iso-1 or iso-2 RNA. Cytochalasin B, phloretin  (24) 
(an  inhibitor of mammalian  facilitated glucose transporters), 
phloridzin (25)  (an  inhibitor f mammalian  Na+-dependent glu- 
cose transporters),  and  FCCP achieve moderate  inhibition of 
transport  in promastigotes and oocytes injected with RNA for 
both isoforms, whereas DCCD inhibits  somewhat  in promas- 
tigotes but not in oocytes. Forskolin,  a potent  inhibitor of mam- 
malian facilitated glucose transporters (261, and  ouabain,  an 
inhibitor of Na+/K+-ATPase and  hence  indirectly of Na+-depend- 
ent  symporters, do not  inhibit  transport  in  any of these sys- 
tems. Hence, the pharmacology of each isoform is similar  to  the 
pharmacology of glucose transport  in promastigotes. Modest 
differences between our  results  in L. enriettii and  the previ- 
ously reported  results  in L. donovani are that: (i) cytochalasin 
B is a less  potent  inhibitor of glucose transport  in L. enriettii, 
producing about 25% inhibition at a 500 p~ concentration com- 
pared to 50% inhibition at 55 PM drug  in L. donovani; (ii) DCCD 
and  FCCP  are not as effective inhibitors  in  the L. enriettii cells 
as  they  are  in L. donovani, where  similar  concentrations inhib- 
ited  transport by approximately 70 and 85%, respectively; and 
(iii)  phloridzin ( 5  mM) is a more effective inhibitor  in L. enriettii 
(about 25%) than it is  in L.  donovani (about 10%). 
DISCUSSION 
During  their life cycle Leishmania parasites  must  adapt  to 
the  markedly different environments of the  sandfly  gut  and  the 
macrophage lysosome. Each of these two habitats  presents a 
different  pH, temperature,  and  range of nutrients  available for 
metabolism. While the promastigotes are exposed to sugars 
such  as glucose when  they  are  in  the sandfly, initially from the 
blood meal and  later from the  plant  sap  meals  that  constitute 
the  sandfly  diet (271, the  amastigotes live in a relatively sugar 
poor intracellular  compartment (6). Furthermore,  promastig- 
otes utilize glucose metabolically at a rather robust rate, 
whereas  amastigotes  are much less  dependent upon glycolysis 
for a source of energy  and rely  more  heavily  upon the oxidation 
of fatty acids (3). Hence, these  parasites  might be expected to 
down-regulate glucose transport upon transformation of pro- 
mastigotes to amastigotes or possibly to  induce expression of a 
different glucose transport  system more  ideally suited for life 
within  the macrophage lysosome. 
In  this paper, we have  investigated  the biological function of 
the Pro-1 genes which are expressed almost exclusively in  the 
promastigote stage of the life cycle and encode proteins  related 
in sequence and structure to mammalian facilitated glucose 
transporters (11). The most  significant conclusion of this work 
is  that  the  Pro-1 genes, whose function was previously  specu- 
lative, do indeed encode proteins  that function as glucose trans- 
porters.  This conclusion has  been proven by the ability of both 
iso-1 and iso-2 to transport the glucose analogue 2-deoxy-~- 
glucose when  each  gene is expressed in Xenopus oocytes. Fur- 
thermore, expression of each  gene  has allowed us to prove that 
these  proteins do have  the previously proposed broad substrate 
specificity and are able to transport other hexoses such as 
fructose and  mannose.  These  results  parallel those of others 
who have previously expressed glucose transporters from mam- 
mals  (28)  and from the  related Kinetoplastid parasite W p a -  
nosoma brucei (29) using  the Xenopus oocyte system. 
The identification of two isoforms of Pro-1  raises  the  question 
of what  distinct biological function  each isoform might perform. 
The observation that both iso-1 and iso-2 have  similar K,  val- 
ues for 2-DOG and closely related patterns of inhibition by 
sugars or other organic  compounds  implies that each isoform 
has  almost  identical  innate biochemical properties. Hence the 
biological distinction  between these two isoforms either: (i) re- 
lies  upon some unique  properties  that we have not  been able  to 
measure with the oocyte system, such as kinetic differences 
that require  interactions  with  other  parasite  proteins ot pres- 
ent  in  the oocytes; or (ii) is conferred by a non-kinetic property 
of the proteins.  One such non-kinetic  distinction  between these 
isoforms might involve unique  subcellular localization of each 
isoform. If iso-1 and iso-2 are differentially localized, then  the 
unique NH,-terminal  domain must contain a localization signal 
in  at  least one of the isoforms. A  precedent for such a dominant 
localization signal  within  the NH, terminus of a glucose trans- 
porter  has  been  suggested for the  insulin-regulated  mamma- 
lian glucose transporter GLUT4 (30, 31). The NH, terminus of 
this  protein is required  to  target GLUT4 to cytoplasmic 
vesicles, and deletion or  alteration of the first 7  amino  acids of 
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this domain causes retargeting of the transporter  to the plasma 
membrane. To address the question of differential targeting, we 
are currently  attempting  to localize each isoform of Pro-1 by 
immunocytochemical methods. 
Although the kinetic properties of iso-1 and iso-2 measured 
in microinjected  oocytes are very similar  to each other, the K, 
values are significantly higher than those measured for pro- 
mastigotes of L.  enriettii. There are several potential explana- 
tions for these differences. The physiological microenvironment 
of the oocytes  may  differ in some significant way  from that of 
the  parasites, leading to an alteration of  the kinetic properties. 
Alternatively, protein-protein interactions present in  the native 
cellular environment may be absent  in the Xenopus expression 
system, which synthesizes only a single parasite protein; these 
putative interactions might lower the I C m  of the  transporter in 
the promastigotes below that which is observed in oocytes. 
However, an alternative  interpretation of the  data is that  the 
K,,, values measured in oocytes are accurate representations of 
the transporter kinetics, and that  the K,,, measured in  intact 
parasites is artifactually low. Since 2-DOG can be phospho- 
rylated by hexokinase, the uptake measurements represent 
both transport and phosphorylation. If phosphorylation is  the 
rate-limiting step  in  total  uptake of  2-DOG within the parasites, 
as reported previously (91, and the ICm for hexokinase is lower 
than  that of the  transporter,  then the K,,, determined from total 
uptake measurements would  be significantly reduced below the 
true K, of the transport  step.  In experiments performed in a 
chemostat (S), ter Kuile and Opperdoes (9) have measured the 
K, for  glucose transport  in L. donouani after correcting for the 
effect of hexokinase and have obtained values ranging from 0.4 
to 0.9 m?a; these values are  in close agreement with those we 
have measured in oocytes expressing either iso-1 or iso-2. Fur- 
thermore, chromatographic analysis (32) of radiolabeled 2-DOG 
accumulated within the oocytes (data not shown) reveals that 
the sugar  is all converted to the phosphorylated form, suggest- 
ing that  the hexokinase step i s  not rate-limiting in  the oocyte 
experiments. Taken together, these  results suggest that  the  true 
K,  values for iso-1 and iso-2 are likely to be within the range 
reported for the oocyte measurements. 
Another important question regarding glucose transport in 
Leishmania parasites is whether  such  transport  is active and 
driven by a proton electrochemical gradient (8) or facilitated 
and governed by dihsion (9). One potential way to resolve this 
issue would  be to  search for a  glucose-~ependent proton current 
by voltage-clamping oocytes expressing iso-1 and iso-2. The 
detection of such a substrate and proton-dependent current 
would constitute very strong evidence in favor of active trans- 
port via proton symport, a mechanism which is believed to 
apply to sugar  transport in several other members of the "fa- 
cilitated glucose transporter superfamily such as  the arabi- 
nose and xylose transporters from Escherichia coli (33). We 
have attempted to measure such currents  in oocytes expressing 
iso-1 or  iso-2 in which the level of  2-DOG transport was occur- 
ring at a rate of 87 pmol  min" per oocyte (at 2 mM 2-DOG).  If 
such oocytes are eo-transporting protons with a stoichiometry 
of 1:1 compared to glucose, a current of approxima~Iy 140 nA 
should be induced. In several such experiments, we have not 
been able to  detect such a proton current. However, since these 
are negative results, no  conclusion can be drawn as to  whether 
glucose transport is truly facilitated or whether it occurs by 
some active but non-electrogenic mechanism such as cotrans- 
port or antiport. 
The ability to ~ c t i o n a l l y  express the Pro-1 transporters 
now opens the route to detailed st~cture-function studies simi- 
lar to those currently being pursued in related  transport sys- 
tems such as  the E. coli lactose permease (34). This advance 
will  allow the combined application of molecular genetic and 
biochemical  tools to the analysis of nutrient  transport  in these 
important pathogens. Studies on such developmentally regu- 
lated membrane transport proteins should  also shed light upon 
the mechanisms whereby these parasites  adapt to  and colonize 
their insect vectors and  their  vertebrate hosts during  the para- 
site life cycle. 
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